{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T08:51:42Z","timestamp":1775638302092,"version":"3.50.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"16","license":[{"start":{"date-parts":[[2018,4,18]],"date-time":"2018-04-18T00:00:00Z","timestamp":1524009600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Anal Bioanal Chem"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1007\/s00216-018-1056-0","type":"journal-article","created":{"date-parts":[[2018,4,18]],"date-time":"2018-04-18T02:19:07Z","timestamp":1524017947000},"page":"3835-3846","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Improved LC-MS\/MS method for the quantification of hepcidin-25 in clinical samples"],"prefix":"10.1007","volume":"410","author":[{"given":"Ioana M.","family":"Abbas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Holger","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"Montes-Bay\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael G.","family":"Weller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,4,18]]},"reference":[{"issue":"17","key":"1056_CR1","doi-asserted-by":"publisher","first-page":"4425","DOI":"10.1182\/blood-2011-01-258467","volume":"117","author":"T Ganz","year":"2011","unstructured":"Ganz T. Hepcidin and iron regulation, 10 years later. Blood. 2011;117(17):4425\u201333. https:\/\/doi.org\/10.1182\/blood-2011-01-258467 .","journal-title":"Blood"},{"issue":"23","key":"1056_CR2","doi-asserted-by":"publisher","first-page":"2809","DOI":"10.1182\/blood-2015-12-639112","volume":"127","author":"D Girelli","year":"2016","unstructured":"Girelli D, Nemeth E, Swinkels DW. Hepcidin in the diagnosis of iron disorders. Blood. 2016;127(23):2809\u201313. https:\/\/doi.org\/10.1182\/blood-2015-12639112.","journal-title":"Blood"},{"issue":"6","key":"1056_CR3","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1039\/C7MT00047B","volume":"9","author":"DJ Hare","year":"2017","unstructured":"Hare DJ. Hepcidin: a real-time biomarker of iron need. Metallomics. 2017;9(6):606\u201318. https:\/\/doi.org\/10.1039\/c7mt00047b.","journal-title":"Metallomics"},{"issue":"3","key":"1056_CR4","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.cmet.2005.02.005","volume":"1","author":"T Ganz","year":"2005","unstructured":"Ganz T. Cellular iron: ferroportin is the only way out. Cell Metab. 2005;1(3):155\u20137. https:\/\/doi.org\/10.1016\/j.cmet.2005.02.005 .","journal-title":"Cell Metab"},{"issue":"1","key":"1056_CR5","doi-asserted-by":"publisher","first-page":"e2009006","DOI":"10.4084\/MJHID.2009.006.","volume":"1","author":"R Mariani","year":"2009","unstructured":"Mariani R, Trombini P, Pozzi M, Piperno A. Iron metabolism in thalassemia and sickle cell disease. Mediterr J Hematol Infect Dis. 2009;1(1):e2009006. https:\/\/doi.org\/10.4084\/MJHID.2009.006.","journal-title":"Mediterr J Hematol Infect Dis"},{"issue":"5704","key":"1056_CR6","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1126\/science.1104742","volume":"306","author":"E Nemeth","year":"2004","unstructured":"Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DM, et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science. 2004;306(5704):2090\u20133. https:\/\/doi.org\/10.1126\/science.1104742 .","journal-title":"Science"},{"issue":"6","key":"1056_CR7","doi-asserted-by":"publisher","first-page":"541","DOI":"10.4155\/bio-2016-0286","volume":"9","author":"S Handley","year":"2017","unstructured":"Handley S, Couchman L, Sharp P, Macdougall I, Moniz C. Bioanalysis measurement of hepcidin isoforms in human serum by liquid chromatography with high resolution mass spectrometry. Bioanalysis. 2017;9(6):541\u201353.","journal-title":"Bioanalysis"},{"issue":"3","key":"1056_CR8","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.chembiol.2010.12.009","volume":"18","author":"RJ Clark","year":"2011","unstructured":"Clark RJ, Tan CC, Preza GC, Nemeth E, Ganz T, Craik DJ. Understanding the structure\/activity relationships of the iron regulatory peptide hepcidin. Chem Biol. 2011;18(3):336\u201343. https:\/\/doi.org\/10.1016\/j.chembiol.2010.12.009 .","journal-title":"Chem Biol"},{"issue":"1","key":"1056_CR9","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1182\/blood-2005-05-2049","volume":"107","author":"E Nemeth","year":"2006","unstructured":"Nemeth E, Preza GC, Jung CL, Kaplan J, Waring AJ, Ganz T. The N-terminus of hepcidin is essential for its interaction with ferroportin: structure-function study. Blood. 2006;107(1):328\u201333. https:\/\/doi.org\/10.1182\/blood-2005-05-2049 .","journal-title":"Blood"},{"issue":"2","key":"1056_CR10","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1586\/17474086.2016.1124757","volume":"9","author":"NL Blanchette","year":"2016","unstructured":"Blanchette NL, Manz DH, Torti FM, Torti SV. Modulation of hepcidin to treat iron deregulation: potential clinical applications. Expert Rev Hematol. 2016;9(2):169\u201386. https:\/\/doi.org\/10.1586\/17474086.2016.1124757 .","journal-title":"Expert Rev Hematol"},{"issue":"1","key":"1056_CR11","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1097\/MAJ.0b013e318253caf1","volume":"345","author":"RT Means Jr","year":"2013","unstructured":"Means RT Jr. Hepcidin and iron regulation in health and disease. Am J Med Sci. 2013;345(1):57\u201360. https:\/\/doi.org\/10.1097\/MAJ.0b013e318253caf1 .","journal-title":"Am J Med Sci"},{"issue":"9","key":"1056_CR12","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.2215\/CJN.05990809","volume":"5","author":"IC Macdougall","year":"2010","unstructured":"Macdougall IC, Malyszko J, Hider RC, Bansal SS. Current status of the measurement of blood hepcidin levels in chronic kidney disease. Clin J Am Soc Nephrol. 2010;5(9):1681\u20139. https:\/\/doi.org\/10.2215\/CJN.05990809.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"9","key":"1056_CR13","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1039\/C4MT00063C","volume":"6","author":"T Konz","year":"2014","unstructured":"Konz T, Montes-Bayon M, Vaulont S. Hepcidin quantification: methods and utility in diagnosis. Metallomics. 2014;6(9):1583\u201390. https:\/\/doi.org\/10.1039\/c4mt00063c.","journal-title":"Metallomics"},{"issue":"12","key":"1056_CR14","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.3324\/haematol.2009.010322","volume":"94","author":"JJ Kroot","year":"2009","unstructured":"Kroot JJ, Kemna EH, Bansal SS, Busbridge M, Campostrini N, Girelli D, et al. Results of the first international round robin for the quantification of urinary and plasma hepcidin assays: need for standardization. Haematologica. 2009;94(12):1748\u201352. https:\/\/doi.org\/10.3324\/haematol.2009.010322 .","journal-title":"Haematologica"},{"issue":"10","key":"1056_CR15","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1002\/ajh.23289","volume":"87","author":"JJ Kroot","year":"2012","unstructured":"Kroot JJ, van Herwaarden AE, Tjalsma H, Jansen RT, Hendriks JC, Swinkels DW. Second round robin for plasma hepcidin methods: first steps toward harmonization. Am J Hematol. 2012;87(10):977\u201383. https:\/\/doi.org\/10.1002\/ajh.23289 .","journal-title":"Am J Hematol"},{"issue":"10","key":"1056_CR16","doi-asserted-by":"publisher","first-page":"e75518","DOI":"10.1371\/journal.pone.0075518","volume":"8","author":"CM Laarakkers","year":"2013","unstructured":"Laarakkers CM, Wiegerinck ET, Klaver S, Kolodziejczyk M, Gille H, Hohlbaum AM, et al. Improved mass spectrometry assay for plasma hepcidin: detection and characterization of a novel hepcidin isoform. PLoS One. 2013;8(10):e75518. https:\/\/doi.org\/10.1371\/journal.pone.0075518 .","journal-title":"PLoS One"},{"issue":"10","key":"1056_CR17","doi-asserted-by":"publisher","first-page":"4292","DOI":"10.1182\/blood-2008-02-139915","volume":"112","author":"T Ganz","year":"2008","unstructured":"Ganz T, Olbina G, Girelli D, Nemeth E, Westerman M. Immunoassay for human serum hepcidin. Blood. 2008;112(10):4292\u20137. https:\/\/doi.org\/10.1182\/blood-2008-02-139915 .","journal-title":"Blood"},{"issue":"2","key":"1056_CR18","doi-asserted-by":"publisher","first-page":"e4581","DOI":"10.1371\/journal.pone.0004581","volume":"4","author":"V Koliaraki","year":"2009","unstructured":"Koliaraki V, Marinou M, Vassilakopoulos TP, Vavourakis E, Tsochatzis E, Pangalis GA, et al. A novel immunological assay for hepcidin quantification in human serum. PLoS One. 2009;4(2):e4581. https:\/\/doi.org\/10.1371\/journal.pone.0004581 .","journal-title":"PLoS One"},{"issue":"1","key":"1056_CR19","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s12185-015-1885-y","volume":"103","author":"L Addo","year":"2016","unstructured":"Addo L, Ikuta K, Tanaka H, Toki Y, Hatayama M, Yamamoto M, et al. The three isoforms of hepcidin in human serum and their processing determined by liquid chromatography-tandem mass spectrometry (LC-tandem MS). Int J Hematol. 2016;103(1):34\u201343. https:\/\/doi.org\/10.1007\/s12185-015-1885-y .","journal-title":"Int J Hematol"},{"key":"1056_CR20","unstructured":"http:\/\/www.drg-diagnostics.de\/files\/eia-5782_ifu--hepcidin-25-bioactive_hs_2017-07-05_endeitesfr.pdf . Accessed 15.11.2017."},{"key":"1056_CR21","doi-asserted-by":"publisher","first-page":"21","DOI":"10.4137\/ACI.S31614","volume":"11","author":"MG Weller","year":"2016","unstructured":"Weller MG. Quality issues of research antibodies. Anal Chem Insights. 2016;11:21\u20137. https:\/\/doi.org\/10.4137\/ACI.S31614 .","journal-title":"Anal Chem Insights"},{"issue":"11","key":"1056_CR22","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1373\/clinchem.2010.151522","volume":"56","author":"AM Butterfield","year":"2010","unstructured":"Butterfield AM, Luan P, Witcher DR, Manetta J, Murphy AT, Wroblewski VJ, et al. A dual-monoclonal sandwich ELISA specific for hepcidin-25. Clin Chem. 2010;56(11):1725\u201332. https:\/\/doi.org\/10.1373\/clinchem.2010.151522 .","journal-title":"Clin Chem"},{"issue":"6","key":"1056_CR23","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1373\/clinchem.2014.221671","volume":"60","author":"N Grebenchtchikov","year":"2014","unstructured":"Grebenchtchikov N, Geurts-Moespot AJ, Trentmann S, Andersen N, Bel Aiba RS, Allersdorfer A, et al. Engineered human lipocalin as an antibody mimetic: application to analysis of the small peptide hormone hepcidin. Clin Chem. 2014;60(6):897\u20139. https:\/\/doi.org\/10.1373\/clinchem.2014.221671 .","journal-title":"Clin Chem"},{"issue":"9","key":"1056_CR24","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1002\/rcm.4512","volume":"24","author":"SS Bansal","year":"2010","unstructured":"Bansal SS, Abbate V, Bomford A, Halket JM, Macdougall IC, Thein SL, et al. Quantitation of hepcidin in serum using ultra-high-pressure liquid chromatography and a linear ion trap mass spectrometer. Rapid Commun Mass Spectrom. 2010;24(9):1251\u20139. https:\/\/doi.org\/10.1002\/rcm.4512 .","journal-title":"Rapid Commun Mass Spectrom"},{"key":"1056_CR25","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.euprot.2014.02.004","volume":"3","author":"C Delaby","year":"2014","unstructured":"Delaby C, Vialaret J, Bros P, Gabelle A, Lefebvre T, Puy H, et al. Clinical measurement of Hepcidin-25 in human serum: is quantitative mass spectrometry up to the job? EuPA Open Proteom. 2014;3:60\u20137. https:\/\/doi.org\/10.1016\/j.euprot.2014.02.004 .","journal-title":"EuPA Open Proteom"},{"issue":"3","key":"1056_CR26","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1182\/blood-2006-11-057471","volume":"110","author":"AT Murphy","year":"2007","unstructured":"Murphy AT, Witcher DR, Luan P, Wroblewski VJ. Quantitation of hepcidin from human and mouse serum using liquid chromatography tandem mass spectrometry. Blood. 2007;110(3):1048\u201354. https:\/\/doi.org\/10.1182\/blood-2006-11-057471 .","journal-title":"Blood"},{"issue":"20","key":"1056_CR27","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.4155\/bio.13.225","volume":"5","author":"B Rochat","year":"2013","unstructured":"Rochat B, Peduzzi D, McMullen J, Bromirski M, Waldvogel S. Validation of hepcidin quantification in plasma using LCHRMS and discovery of a new hepcidin isoform. Bioanalysis. 2013;5(20):2509\u201320.","journal-title":"Bioanalysis"},{"issue":"19","key":"1056_CR28","doi-asserted-by":"publisher","first-page":"8133","DOI":"10.1021\/ac300578n","volume":"84","author":"T Konz","year":"2012","unstructured":"Konz T, Montes-Bayon M, Sanz-Medel A. Elemental labeling and isotope dilution analysis for the quantification of the peptide hepcidin-25 in serum samples by HPLC-ICP-MS. Anal Chem. 2012;84(19):8133\u20139. https:\/\/doi.org\/10.1021\/ac300578n .","journal-title":"Anal Chem"},{"key":"1056_CR29","first-page":"10","volume":"15","author":"www.hepcidinanalysis.com","year":"2017","unstructured":"www.hepcidinanalysis.com. Access. 2017;15:10.","journal-title":"Access"},{"key":"1056_CR30","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1002\/mas.1280110402","volume":"11","author":"A Leenheer de","year":"1992","unstructured":"de Leenheer A, Thienpont L. Applications of isotope dilution-mass spectrometry in clinical chemistry, pharmacokinetics, and toxicology. Mass Spectrom Rev. 1992;11:249\u2013307. https:\/\/doi.org\/10.1002\/mas.1280110402 .","journal-title":"Mass Spectrom Rev"},{"issue":"3\u20135","key":"1056_CR31","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.jsbmb.2010.02.017","volume":"121","author":"C Shackleton","year":"2010","unstructured":"Shackleton C. Clinical steroid mass spectrometry: a 45-year history culminating in HPLC-MS\/MS becoming an essential tool for patient diagnosis. J Steroid Biochem Mol Biol. 2010;121(3\u20135):481\u201390. https:\/\/doi.org\/10.1016\/j.jsbmb.2010.02.017 .","journal-title":"J Steroid Biochem Mol Biol"},{"key":"1056_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.trac.2016.04.018","volume":"84","author":"M Vogeser","year":"2016","unstructured":"Vogeser M, Seger C. Mass spectrometry methods in clinical diagnostics\u2014state of the art and perspectives. TrAC Trends Anal Chem. 2016;84:1\u20134. https:\/\/doi.org\/10.1016\/j.trac.2016.04.018 .","journal-title":"TrAC Trends Anal Chem"},{"issue":"36","key":"1056_CR33","doi-asserted-by":"publisher","first-page":"24155","DOI":"10.1074\/jbc.M109.017764","volume":"284","author":"JB Jordan","year":"2009","unstructured":"Jordan JB, Poppe L, Haniu M, Arvedson T, Syed R, Li V, et al. Hepcidin revisited, disulfide connectivity, dynamics, and structure. J Biol Chem. 2009;284(36):24155\u201367. https:\/\/doi.org\/10.1074\/jbc.M109.017764.","journal-title":"J Biol Chem"},{"issue":"7","key":"1056_CR34","doi-asserted-by":"publisher","first-page":"e2706","DOI":"10.1371\/journal.pone.0002706","volume":"3","author":"DW Swinkels","year":"2008","unstructured":"Swinkels DW, Girelli D, Laarakkers C, Kroot J, Campostrini N, Kemna EH, et al. Advances in quantitative hepcidin measurements by time-of-flight mass spectrometry. PLoS One. 2008;3(7):e2706. https:\/\/doi.org\/10.1371\/journal.pone.0002706 .","journal-title":"PLoS One"},{"issue":"1","key":"1056_CR35","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1373\/clinchem.2015.250563.","volume":"62","author":"AN Hoofnagle","year":"2016","unstructured":"Hoofnagle AN, Whiteaker JR, Carr SA, Kuhn E, Liu T, Massoni SA, et al. Recommendations for the generation, quantification, storage, and handling of peptides used for mass spectrometry-based assays. Clin Chem. 2016;62(1):48\u201369. https:\/\/doi.org\/10.1373\/clinchem.2015.250563.","journal-title":"Clin Chem"},{"issue":"6","key":"1056_CR36","doi-asserted-by":"publisher","first-page":"859","DOI":"10.4155\/bio.14.36","volume":"6","author":"J Zheng","year":"2014","unstructured":"Zheng J, Mehl J, Zhu Y, Xin B, Olah T. Application and challenges in using LC-MS assays for absolute quantitative analysis of therapeutic proteins in drug discovery. Bioanalysis. 2014;6(6):859\u201379.","journal-title":"Bioanalysis"},{"issue":"1","key":"1056_CR37","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.ab.2011.02.009","volume":"414","author":"M Goebel-Stengel","year":"2011","unstructured":"Goebel-Stengel M, Stengel A, Tache Y, Reeve JR Jr. The importance of using the optimal plasticware and glassware in studies involving peptides. Anal Biochem. 2011;414(1):38\u201346. https:\/\/doi.org\/10.1016\/j.ab.2011.02.009 .","journal-title":"Anal Biochem"},{"issue":"5","key":"1056_CR38","doi-asserted-by":"publisher","first-page":"e0122419","DOI":"10.1371\/journal.pone.0122419","volume":"10","author":"K Kristensen","year":"2015","unstructured":"Kristensen K, Henriksen JR, Andresen TL. Adsorption of cationic peptides to solid surfaces of glass and plastic. PLoS One. 2015;10(5):e0122419. https:\/\/doi.org\/10.1371\/journal.pone.0122419 .","journal-title":"PLoS One"},{"issue":"7\u20138","key":"1056_CR39","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.cca.2011.12.015","volume":"413","author":"O Itkonen","year":"2012","unstructured":"Itkonen O, Parkkinen J, Stenman UH, Hamalainen E. Preanalytical factors and reference intervals for serum hepcidin LC-MS\/MS method. Clin Chim Acta. 2012;413(7\u20138):696\u2013701. https:\/\/doi.org\/10.1016\/j.cca.2011.12.015 .","journal-title":"Clin Chim Acta"},{"key":"1056_CR40","unstructured":"Clarke W, Molinaro RJ, Bachmann LM, Botelho JC, Cao Z, French SG et al. Liquid chromatography-mass spectrometry methods; approved guideline. C62-A. 2014;34(16)."},{"key":"1056_CR41","unstructured":"https:\/\/publications.europa.eu\/en\/publication-detail\/-\/publication\/ed928116-a955-4a84-b10a-cf7a82bad858\/language-en . Accessed 15.11.2017."},{"key":"1056_CR42","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.talanta.2013.03.048","volume":"115","author":"A Furey","year":"2013","unstructured":"Furey A, Moriarty M, Bane V, Kinsella B, Lehane M. Ion suppression; a critical review on causes, evaluation, prevention and applications. Talanta. 2013;115:104\u201322. https:\/\/doi.org\/10.1016\/j.talanta.2013.03.048 .","journal-title":"Talanta"},{"key":"1056_CR43","doi-asserted-by":"publisher","first-page":"25162","DOI":"10.1038\/srep25162","volume":"6","author":"C Hirtz","year":"2016","unstructured":"Hirtz C, Vialaret J, Gabelle A, Nowak N, Dauvilliers Y, Lehmann S. From radioimmunoassay to mass spectrometry: a new method to quantify orexin-A (hypocretin-1) in cerebrospinal fluid. Sci Rep. 2016;6:25162. https:\/\/doi.org\/10.1038\/srep25162 .","journal-title":"Sci Rep"},{"issue":"10","key":"1056_CR44","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1373\/clinchem.2010.149187","volume":"56","author":"JJ Kroot","year":"2010","unstructured":"Kroot JJ, Laarakkers CM, Geurts-Moespot AJ, Grebenchtchikov N, Pickkers P, van Ede AE, et al. Immunochemical and mass-spectrometry-based serum hepcidin assays for iron metabolism disorders. Clin Chem. 2010;56(10):1570\u20139. https:\/\/doi.org\/10.1373\/clinchem.2010.149187 .","journal-title":"Clin Chem"},{"issue":"Suppl. 1","key":"1056_CR45","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1747-0285.2006.00328.x","volume":"66","author":"S Melino","year":"2005","unstructured":"Melino S, Garlando L, Patamia M, Paci M, Petruzzelli R. A metal-binding site is present in the structure of hepcidin. J Pept Res. 2005;66(Suppl. 1):65\u201371.","journal-title":"J Pept Res"},{"issue":"2","key":"1056_CR46","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1042\/BJ20091521","volume":"427","author":"C Tselepis","year":"2010","unstructured":"Tselepis C, Ford SJ, McKie AT, Vogel W, Zoller H, Simpson RJ, et al. Characterization of the transition-metal-binding properties of hepcidin. Biochem J. 2010;427(2):289\u201396. https:\/\/doi.org\/10.1042\/BJ20091521.","journal-title":"Biochem J"},{"issue":"24","key":"1056_CR47","doi-asserted-by":"publisher","first-page":"10116","DOI":"10.1021\/ac102179j","volume":"82","author":"B Maclean","year":"2010","unstructured":"Maclean B, Tomazela DM, Abbatiello SE, Zhang S, Whiteaker JR, Paulovich AG, et al. Effect of collision energy optimization on the measurement of peptides by selected reaction monitoring (SRM) mass spectrometry. Anal Chem. 2010;82(24):10116. https:\/\/doi.org\/10.1021\/ac102179j .","journal-title":"Anal Chem"},{"issue":"10","key":"1056_CR48","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1515\/cclm-2014-1093","volume":"53","author":"T Lefebvre","year":"2015","unstructured":"Lefebvre T, Dessendier N, Houamel D, Ialy-Radio N, Kannengiesser C, Manceau H, et al. LC-MS\/MS method for hepcidin-25 measurement in human and mouse serum: clinical and research implications in iron disorders. Clin Chem Lab Med. 2015;53(10):1557\u201367. https:\/\/doi.org\/10.1515\/cclm-2014-1093.","journal-title":"Clin Chem Lab Med"},{"issue":"1\u20132","key":"1056_CR49","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s10337-014-2808-4","volume":"78","author":"X Zheng","year":"2014","unstructured":"Zheng X, Chen X, Jian N, Chen J, Hu P, Jiang J. A rapid and sensitive LC\u2013MS\u2013MS method for determination of hepcidin-25 in human serum, and measurement of its diurnal rhythm for healthy subjects. Chromatographia. 2014;78(1\u20132):73\u201380. https:\/\/doi.org\/10.1007\/s10337-014-2808-4 .","journal-title":"Chromatographia"},{"issue":"25","key":"1056_CR50","doi-asserted-by":"publisher","first-page":"e218","DOI":"10.1182\/blood-2011-02-337907","volume":"117","author":"TE Galesloot","year":"2011","unstructured":"Galesloot TE, Vermeulen SH, Geurts-Moespot AJ, Klaver SM, Kroot JJ, van Tienoven D, et al. Serum hepcidin: reference ranges and biochemical correlates in the general population. Blood. 2011;117(25):e218\u201325. https:\/\/doi.org\/10.1182\/blood-2011-02-337907 .","journal-title":"Blood"},{"issue":"9","key":"1056_CR51","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1373\/clinchem.2008.107029","volume":"54","author":"U Kobold","year":"2008","unstructured":"Kobold U, D\u00fclffer T, dangl M, Escherich A, Kubbies M, R\u00f6ddiger R, et al. Quantification of hepcidin-25 in huma n serum by isotope dilution micro-HPLC\u2013tandem mass spectrometry. Clin Chem. 2008;54(9):1584\u20136. https:\/\/doi.org\/10.1373\/clinchem.2008.107029 .","journal-title":"Clin Chem"},{"issue":"7","key":"1056_CR52","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1373\/clinchem.2016.256768","volume":"62","author":"LN Vorm van der","year":"2016","unstructured":"van der Vorm LN, Hendriks JC, Laarakkers CM, Klaver S, Armitage AE, Bamberg A, et al. Toward worldwide hepcidin assay harmonization: identification of a commutable secondary reference material. Clin Chem. 2016;62(7):993\u20131001. https:\/\/doi.org\/10.1373\/clinchem.2016.256768 .","journal-title":"Clin Chem"}],"container-title":["Analytical and Bioanalytical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00216-018-1056-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00216-018-1056-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00216-018-1056-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T03:17:10Z","timestamp":1720235830000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00216-018-1056-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,18]]},"references-count":52,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["1056"],"URL":"https:\/\/doi.org\/10.1007\/s00216-018-1056-0","relation":{},"ISSN":["1618-2642","1618-2650"],"issn-type":[{"value":"1618-2642","type":"print"},{"value":"1618-2650","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,18]]},"assertion":[{"value":"5 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The experiments with human serum were conducted with commercially available materials purchased from Dunn Labortechnik, Asbach, Germany.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}